World Rx drug sales up 10% in year to Feb

26 April 2001

Total retail pharmacy drug sales in the world's 13 major markets grew10% overall in the 12 months to February 2001, closing at $223.61 billion, say the latest figures from IMS Health, which notes that this is the same rate of rise as was reported for the 12 months to January.

The world market continued to be driven by the USA, where sales rose 15% to $100.18 billion, up 1% on the previous reporting period. Canada was also up 15%, at $5.59 billion, and fast growth was additionally reported for Mexico, up 18% to $4.96 billion, Australia/New Zealand, rising 13% to $3.85 billion, and Italy, which advanced 10% to $8.86 billion.

The five leading European markets rose 7% overall to $50.66 billion, which is a 1% fall over the 12 months to January. The fastest growth was seen in Italy, followed by Spain, which increased 9% to $5.30 billion, France rising 8% to $13.20 billion and Germany and the UK advancing 6% each, to $14.40 billion and $8.87 billion respectively.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight